Press release BoxID: 140232 (biolitec biomedical technology GmbH)
  • biolitec biomedical technology GmbH
  • Otto-Schott-Str. 15
  • 07745 Jena
  • Contact person
  • Ariane Oltmanns
  • +49 (3641) 5085-54

biolitec AG Decides to Raise Cash by Means of Share Capital Increase under Exclusion of Subscription Rights

(PresseBox) (Jena, ) Today the Executive Board of the company biolitec AG (Frankfurt, Prime Standard: BIB) decided, with the Supervisory Board's consent, to increase the company's share capital from EUR 10,015,000.00 by EUR 1,001,499.00 up to EUR 11,016,499.00, by cash contribution and partly utilizing the approved capital. The capital increase is carried out under exclusion of subscription rights. As Sole Lead Manager ICF Kursmakler AG will offer the new shares with institutional investors in Germany and Europe at a price close to market by means of an accelerated bookbuilding process.

The proceeds from the capital increase are intended for the further expansion of the sales force as well as for financing research and development projects in the future.